CIBC World Markets’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$116K Sell
15,896
-12,397
-44% -$100K ﹤0.01% 1381
2025
Q1
$269K Buy
28,293
+16,361
+137% +$204K ﹤0.01% 1304
2024
Q4
$197K Buy
+11,932
New +$185K ﹤0.01% 1140

Other funds holding NEO

CIBC World Markets's NEO Position: Q2 2025 in Review

CIBC World Markets reduced its NeoGenomics (NEO) stake by 44% in Q2 2025, selling an estimated $100K and leaving 15,896 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

CIBC World Markets first reported a position in NEO in Q4 2024 and has held it in 3 quarters since. The position peaked at $269K in Q1 2025. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

  • CIBC World Markets held 15,896 shares of NeoGenomics worth $116K as of Q2 2025.
  • CIBC World Markets sold 12,397 NeoGenomics shares in Q2 2025, an estimated $100K.
  • NeoGenomics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1381 holding.
  • CIBC World Markets first reported a position in NeoGenomics in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's NeoGenomics position peaked at $269K in Q1 2025.
  • 274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.